Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06449482
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2023-06-13
Brief Title:
SelinexorVenetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-13
First Submit QC Date:
June 3 2024
Study First Post Date:
2024-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-03
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL